Streicher, Caroline
Axsome Therapeutics (United States)
4 papers on CoChatORCID 0000-0002-1230-738X
Most cited papers
- Verified
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Suppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 322
- Verified
Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder
Iosifescu, D. V., Jones, A., O’Gorman, C., Streicher, C., Feliz, S., Fava, M., & Tabuteau, H. (2022) · The Journal of Clinical Psychiatry
Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects
Cited by 135
- Verified
Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder
Calabrese, J. R., Pikalov, A., Streicher, C., Cucchiaro, J., Mao, Y., & Loebel, A. (2017) · European Neuropsychopharmacology
Bipolar Disorder and TreatmentTreatment of Major Depression
Cited by 55
- Verified
Improvement in Anxiety Symptoms in Depressed Patients Treated With AXS-05 (DEXTROMETHORPHAN-BUPROPION): Results From the Evolve Open-Label, Long-Term Study
Jones, A., Streicher, C., Alter, S., Thomas, Z., & Tabuteau, H. (2023) · CNS Spectrums
Treatment of Major DepressionPharmacological Receptor Mechanisms and Effects
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free